Suministro de medicamentos exclusivos: Ustekinumab (Stelara), Guselkumab (Tremfya), Secukinumab (Cosentyx), Brodalumab, (Kyntheum) e Ixekizumab (Taltz).2ª Prórroga P.N.S.P. 16/2019.

Contract type	Supplies
CPV	33600000
Awarded to	Janssen Cilag, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.